Aim-To determine whether the urokinase plasminogen activator receptor (u-PAR; CD87) exhibits a possible pathogenic role in rheumatoid and osteoarthritis.
Rheumatoid arthritis is a chronic inflammatory disease characterised by the transendothelial ingress of leucocytes into synovial tissue that is rich in newly formed blood vessels.' A regulatory network of inflammatory cells and mediators, as well as cellular adhesion molecules (CAMs) play an important role in the pathogenesis of rheumatoid arthritis.3 4 Angiogenesis is crucial for the perpetuation of leucocyte extravasation into the synovial tissue in rheumatoid arthritis.5 These elements have also been implicated, although to a lesser extent, in osteoarthritis, an essentially degenerative joint disease with inflammatory features.4 6 There is substantial data suggesting that the urokinase plasminogen activator (u-PA), which is highly involved in the proteolytic joint destruction underlying arthritis, interacts with a number of participants in the regulatory network described above. u-PA, a serine protease, activates a cascade of proteolysis, leading to extracellular matrix (ECM) degradation, and thus it is involved in cell adhesion, migration, and proteolysis underlying tumour invasion, inflammation, angiogenesis, and tissue remodelling.7'-0 The 50 to 65 kD u-PA receptor (u-PAR), which binds to the N-terminal end of u-PA and localises u-PA at the cell surface, has recently been clustered as CD87. 1-4 u-PAR is a monocyte activation antigen'3 15 that also plays a role during macrophage differentiation. '6 There are some data available on the roles of u-PA and u-PAR in inflammatory conditions, including arthritis. Little u-PA is produced by resting monocytes/macrophages, T lymphocytes, endothelial cells, chondrocytes, and synoviocytes. However, the secretion of u-PA by these cells and the expression ofu-PAR on monocytes and endothelia is highly up-regulated on the activation of these cells by a number of inflammatory and angiogenic mediators. 17-26 u-PAR is a glycosyl-phosphatidylinositol (GPI) anchored protein, which forms a complex with the (2 integrins on monocytes.27 28 It also interacts with other CAMs and ECM components, such as P13 and 13 integrins, and vitronectin on the cell surface. 26 29-31 The co-capping of u-PAR with other CAMs on the cell surface, which involves cyclic AMP dependent and protein kinase C dependent signalling, results in the induction of leucocyte adhesion and chemotaxis.'62732 33 The increased production of u-PA by cytokine-stimulated endothelial cells and the up-regulated expression of u-PAR in association with integrins on leucocytes plays an important role in leucocyteendothelial interactions and angiogenesis underlying inflammation.
Some data are available on the abundant production of u-PA and u-PAR in rheumatoid arthritis. Increased levels of u-PA and u-PAR were detected in synovial tissue extracts from rheumatoid versus osteoarthritis patients.34
The concentration of u-PA was also increased in synovial fluids from rheumatoid versus osteoarthritis patients.35 36 In a preliminary study, most myeloid, and some endothelial cells in the synovial tissue from rheumatoid and osteoarthritis patients showed immunoreactivity with the lOG7 monoclonal antibody (MoAb).37
This MoAb was later found to recognise transfectants bearing u-PAR. Descriptive immunohistochemistry performed by others revealed strong expression of u-PA and u-PAR in myeloid cells in the rheumatoid arthritis synovial tissue.34 3 Cell types present in synovial tissue were identified by their morphology after haematoxylin counterstaining, and by using the aforementioned positive control MoAb. Synovial tissue samples were assigned scores for the number of macrophages, degree of inflammation, and the number of blood vessels on a relative scale of 1 to 3, with 3 being the highest score (for example, a macrophage score of 1, 2, and 3 represented < 25, 25-100, and > 100 macrophages per x400 microscopic field, respectively). Inflammatory and vessel scores were obtained similarly. The specific cell types evaluated in the synovial tissue were lining cells, subsynovial macrophages, fibroblasts, vascular endothelium, vascular smooth muscle, and lymphocytes. All immunostaining of synovial tissue components was graded by frequency on a scale of 0% to 100%, where 0% indicated no staining and 100% showed that all cells were immunoreactive. Five x400 fields were examined per section. Data were pooled and the mean (SEM) was calculated for each data group. In addition, presence ("positive tissues" with > 10% immunoreactive cells) or absence ("negative tissues" with < 10% immunoreactive cells) of cellular immunoreactivity with MoAb 10G7 was also noted in each tissue. Specimens were analysed by one investigator (GKH) as a blinded observer and, in the case of selected synovial tissue samples, also by the other two investigators. In general, no major differences were found between the analysis of the three observers.
Corresponding data groups were compared using an independent t test. In addition, all inflammatory, macrophage, and vessel scores, as well as synovial tissue lining, macrophage, and endothelial immunoreactivity values were pooled, regardless of whether they were obtained from rheumatoid arthritic, osteoarthritic or normal synovial tissue, resulting in a total of 24 values in each data group. A multiway Pearson correlation analysis was performed between any two of these data groups. p < 0.05 was considered significant.
Results
Synovial tissue from rheumatoid arthritis patients exhibited a significantly higher inflammatory score (2.1 (0.3)), macrophage score (2.3 (0.3)), and vessel score (2.6 (0.2)) than tissue from patients with osteoarthritis (1.3 (0.1), 1.4 (0.2), 1.9 (0.1), respectively) or normal synovial tissue (1 (0), 1 (0), 2 tissue sample. 34 We analysed cells expressing u-PAR, but not u-PAR expression on the cell number of u-PARs is increase( blood monocytes form rheun patients compared with osteoar and normal subjects. 46 There most myeloid cells express u-I from both rheumatoid and osi tients, the number of receptors may be much lower in synov osteoarthritis patients resulting ferences in sensitivity between ours. Alternatively, tissue fron patients included in our study inflamed that the ones used by t However, we have also reporte GPI linked myeloid antigen, C up-regulated on synovial tissue macrophages in rheumatoid an versus normal synovia. and joint destruction in a number of ways. u-PA may be involved in the recruitment of inflammatory leucocytes into the synovial tissue, as it is chemotactic for neutrophils48 and it stimulates cytokine dependent monocyte adhesion.33 u-PAR has been identified as the monocyte activation antigen Mo-3,'5 and its soluble form has been detected in the conditioned media of activated monocytes.'3 u-PAR is involved in macrophage differentiation, monocyte derived pericellular proteolysis, adhesion to the ECM, and the stimulation of metalloproteinase production.'6 u-PA is also a potent mediator of angiogenesis.'°Cytokine stimulated endothelia produce high amounts of u-PA that, in turn, 
